Live news , top stories, corporate news, company news, sector news, economy news, results analysis news, ceo interviews, fund manager interview, advisor interview, market news, bazaar talk, hot stocks news, ipo news, commodities news, mutual fund news, insurance news, news wire
22 September, 2018 05:17 IST
Jubilant Life Sciences gets final nod for Niacin ER tablets
Source: IRIS | 15 May, 2018, 03.28PM
Comments  |  Post Comment

Jubilant Life Sciences, an integrated global Pharmaceutical and Life Sciences Company, has announced that Jubilant Pharma, a material wholly owned subsidiary of the company, through one of its wholly owned subsidiaries, has received Abbreviated New Drug Application (ANDA) final approval for Niacin Extended-Release Tablets USP, 500 mg, 750 mg, and 1,000 mg, the generic version of Niaspan of AbbVie, which is indicated to reduce elevated TC, LDLC, Apo B and TG, and to increase HDL-C in patients with primary hyperlipidemia and mixed dyslipidemia thereby reducing the risk of recurrent nonfatal myocardial infarction in patients with a history of myocardial infarction and hyperlipidemia.

This is the first approval that we have received from the USFDA during the current financial year. As on March 31, 2018, Jubilant (Q,N,C,F)* had a total of 94 ANDAs for Oral Solids filed in the US, of which 59 had been approved and 12 Sterile (Injectables & Ophthlamics) filings, of which 10 had been approved.

Shares of the company declined Rs 20.9, or 2.48%, to trade at Rs 822.65. The total volume of shares traded was 29,580 at the BSE (3.13 p.m., Tuesday).



Comments Post comment 
 Post Comment
Name Email
Comment
Security Code type    into this box
Sector
ITD Cementation India wins orders worth Rs 8.45 bn - 21-Sep-2018 15:44
Emami Paper Mills to invest around Rs 20 bn in Gujarat - 21-Sep-2018 15:03
Tijaria Polypipes receives single order worth Rs 353 mn - 21-Sep-2018 13:13
Infosys to open technology and innovation hub in Arizona - 21-Sep-2018 13:08
Pennar Group bags orders worth Rs 1.81 bn - 21-Sep-2018 13:05
TCS recognized as leader in finance and accounting digital augmentation suite - 21-Sep-2018 12:30
Meera lndustries bags order worth USD 105,000 - 21-Sep-2018 12:15
Sun Pharma announces Australian TGA approval of ILUMYA - 21-Sep-2018 12:06
Fitch revises outlook on Tata Motors to negative; affirms at BB+ - 21-Sep-2018 10:55
SBI, QCI sign MoU on Zero Defect Zero Effect Certification for MSMEs - 21-Sep-2018 09:50
TCS partners with The Training Room, UK - 21-Sep-2018 09:46
more...
Home  |   Shares  |   F&O  |   Mutual Funds  |   Loans  |   Insurance  |   News Centre
Wealth Tracker  |   Newsletters  |   Tax Corner  |   NRI Centre  |   Advertise
© All rights reserved. IRIS Business Services Limited
A Disclaimer